Table 2.
Impact of baseline covariates on (1) odds of receiving ARB relative to ACEI and (2) follow up Hgb levels (Factors Used in Doubly Robust Analysis)
| |
Effect on follow up Hgb in g/dL (95% CI) |
|||
|---|---|---|---|---|
| |
|
Overall |
ACEI |
ARB |
| Baseline covariate | OR (95% CI) for receiving ARB relative to ACEI | (N = 701) | (N = 519) | (N = 182) |
| AGE |
1.00 (0.98, 1.02) |
0.00 (−0.01, 0.01) |
−0.00 (−0.01, 0.01) |
−0.00 (−0.02, 0.02) |
| Sex (female) |
1.40 (0.96, 2.05) |
−0.32 (−0.47, -0.17) |
−0.29 (−0.47, -0.11) |
−0.47 (−0.75, -0.20) |
| Diabetes mellitus |
1.16 (0.81, 1.67) |
0.01 (−0.14, 0.15) |
−0.03 (−0.20, 0.15) |
0.15 (−0.13, 0.42) |
| Hypertension |
2.82 (1.12, 7.13) |
0.29 (−0.01, 0.58) |
0.21 (−0.12, 0.54) |
0.49 (−0.24, 1.22) |
| CHF |
1.90 (0.98, 3.68) |
0.42 (0.14, 0.70) |
0.56 (0.20, 0.91) |
0.13 (−0.33, 0.58) |
| Hgb (pre) |
0.89 (0.78, 1.02) |
0.59 ( 0.53, 0.64) |
0.60 (0.54, 0.66) |
0.57 (0.48, 0.66) |
| CKD |
1.19 (0.75, 1.89) |
−0.15 (−0.34, 0.04) |
−0.09 (−0.31, 0.14) |
−0.31 (−0.64, 0.03) |
| Year of initiation of treatment | 0.86 (0.74, 1.01) | −0.05 (−0.11, 0.01) | −0.05 (−0.13, 0.02) | −0.03 (−0.15, 0.09) |